That’s a bit harsh given Denmark’s strong growth compared with neighboring countries over the past few years has been largely ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index, which ...

"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...